Related by context. Frequent words. (Click for all words.) 73 adecatumumab 72 Azedra 72 CCX# 72 pertuzumab 72 goserelin 71 ApoB SNALP 71 Phase Ib clinical 71 MEK inhibitor 71 metastatic hormone refractory 71 CR# vcMMAE 71 KNS # 71 deforolimus 71 Amrubicin 70 Vandetanib 70 elotuzumab 70 HGS ETR1 70 DAVANAT 70 EZN 70 ATL# [001] 70 Sym# 70 OncoVEX GM CSF 70 imetelstat 69 HER2 positive metastatic breast 69 Trastuzumab 69 APOPTONE 69 Imprime PGG 69 talabostat 69 Traficet EN 69 IMC A# 69 eniluracil 69 axitinib 69 CYC# 69 drug conjugate 69 tanespimycin 69 tesmilifene 69 Gemzar ® 69 nab paclitaxel 69 relapsed multiple myeloma 69 Irinotecan 69 GRN#L 69 atacicept 69 antiangiogenic 69 Natalizumab 68 orally bioavailable 68 luteinizing hormone releasing 68 Aurora kinase 68 Virulizin R 68 pharmacodynamic effects 68 OXi# 68 CA4P 68 angiogenesis inhibitor 68 BAY #-# 68 Voreloxin 68 MORAb 67 CoFactor 67 Asentar 67 Carfilzomib 67 Panzem R 67 Pivotal Phase 67 BrachySil 67 Phase 2a trial 67 HCV protease inhibitor 67 NVA# 67 Pivotal Phase III 67 anticancer compound 67 ISTODAX 67 PRX# 67 thymalfasin 67 HuMax CD# 67 decitabine 67 KRN# 67 temsirolimus 67 Bortezomib 67 LY# [003] 67 custirsen 66 PEG Interferon lambda 66 PEGylated 66 humanized anti 66 daunorubicin 66 BNC# 66 Rebif ® 66 novel anticancer 66 INGN 66 StemEx 66 Gemcitabine 66 Nexavar ® 66 Cloretazine R VNP#M 66 GVAX 66 Allovectin 7 R 66 PARP inhibitor 66 carboplatin paclitaxel 66 TORISEL 66 IMGN# 66 relapsed refractory multiple myeloma 66 chemotherapeutic drug 66 MDV# 66 seliciclib 66 Diamyd ® 66 Erlotinib 66 placebo controlled clinical 66 MNTX